Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Data: In March, there were 20 major hacking incidents in the crypto industry, with total losses reaching 52 million USD.

Data: In March, there were 20 major hacking incidents in the crypto industry, with total losses reaching 52 million USD.

金色财经金色财经2026/04/01 04:40
Show original
Jinse Finance reported that on April 1, according to monitoring by PeckShield, there were a total of 20 major hacking incidents in the crypto industry in March 2026, with total losses reaching $52 million, a month-on-month surge of 96% compared to February ($26.5 million). However, an even greater risk lies in the so-called "shadow contagion effect."Main attack incidents: Resolv Labs ($USR) depegging: An AWS KMS vulnerability was exploited, leading to an "infinite issuance" of 80 million USR, causing about $25 million in losses. An 80% price drop further triggered systemic bad debt across protocols such as Morpho Blue, Euler, and Fluid.Venus Protocol ($THE): A complex attack combining on-chain and off-chain methods resulted in about $2.18 million in bad debt.Physical and social engineering attacks: sillytuna suffered around $24 million in combined physical and on-chain attacks, while a whale at a certain exchange lost $18 million due to a targeted social engineering attack.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Moderna plunges by as much as 26%, setting a record for the biggest single-day drop! Melanoma vaccine data leaked early, results fall short of expectations

Clinical trial data from phase 3 of the personalized melanoma vaccine jointly developed by Moderna and Merck was unexpectedly leaked ahead of schedule. The data showed a 42% reduction in cancer recurrence risk and a 38% reduction in risk of distant metastasis. These results fell short of market expectations, as an earlier study had shown the combination therapy could reduce recurrence risk by 49% and distant metastasis risk by 59%. Moderna's stock price plunged as much as 26% intraday, later rebounded partially, and ultimately closed down 17.6%.

华尔街见闻•2026/10/22 21:01